Sonoma Pharmaceuticals
SNOA
#10371
Rank
C$5.83 M
Marketcap
C$3.37
Share price
0.20%
Change (1 day)
-33.16%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -C$4.39 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are C$16.93 Million. In 2024 the company made an earning of -C$6.13 Million a decrease over its 2023 earnings that were of -C$6.1 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$4.39 Million-28.45%
2024 -C$6.13 Million0.54%
2023 -C$6.1 Million-31.5%
2022 -C$8.9 Million16.86%
2021 -C$7.61 Million194.32%
2020 -C$2.59 Million-58.76%
2019 -C$6.27 Million-65.66%
2018 -C$18.26 Million4.84%
2017 -C$17.42 Million-2.17%
2016 -C$17.81 Million32.12%
2015 -C$13.48 Million-307.74%
2014 C$6.48 M-197.5%
2013 -C$6.66 Million
2010 -C$10.4 Million-14.02%
2009 -C$12.09 Million-57.28%
2008 -C$28.3 Million-8.03%
2007 -C$30.77 Million3.85%
2006 -C$29.63 Million39.31%
2005 -C$21.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.22 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$24.92 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA